RIA Advisory Group »

Regeneron Pharmaceuticals shares owned by RIA Advisory Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by RIA Advisory Group from 13F filings

Historical chart of RIA Advisory Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by RIA Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by RIA Advisory Group

Quarter filed Position value Share count Share price at filing
2023-03-31 $431k 524 821.67
2022-12-31 $391k 542 721.53

More positions owned by RIA Advisory Group

Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr S&p 100 Etf (OEF)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Silver Tr Ishares (SLV)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Proshares Tr Pshs Ultra Qqq (QLD)
NVIDIA Corporation (NVDA)
Proshares Tr Pshs Ult S&p 500 (SSO)
Microsoft Corporation (MSFT)
Verizon Communications (VZ)
Ishares Tr Short Treas Bd (SHV)
McDonald's Corporation (MCD)

View all positions for RIA Advisory Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals